The cardiovascular profile of semaglutide has been extensively studied in landmark trials
For GLP-1 users specifically, the benchmarking approach is useful because it gives you concrete evidence of whether your strength is being preserved or declining during weight loss, something that is otherwise very difficult to track without baseline data
This is a known limitation of using real-world EHR data, and our results should be interpreted with this context in mind
Publisher | Google Scholor Aimelet V, Holst JJ
Four of the articles reviewed showed that there was increased incidence of aspiration among GLP-1 RA users (Australian Diabetes Society, National Association of Clinical Obesity Services, Gastroenterological Society of Australia, and Australian and New Zealand College of Anaesthetists n.d.)
In one case series of three cats, diagnosis of GERD was based on clinical signs, contrast radiography, and endoscopic findings